Lyme Arthritis: Pathogenesis, Clinical Presentation, and Management

Infectious Disease Clinics of North America

Volumn 22, Issue 2, 2008, Pages 289-300

  Puius, Yoram A ^a   Kalish, Robert A ^b,c  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; DOXYCYCLINE; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANTIBIOTIC THERAPY; ARTHRALGIA; ARTHRITIS; BORRELIA BURGDORFERI; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LYME DISEASE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; RECOMMENDED DRUG DOSE; REVIEW; SEROLOGY; SYNOVECTOMY; WESTERN BLOTTING;

ACUTE DISEASE; ARTHRALGIA; CHRONIC DISEASE; HUMANS; LYME DISEASE;

EID: 42949175035     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2007.12.014     Document Type: Review

References (43)

1. Steere A.C., Malawista S.E., Snydman D.R., et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 20 (1977) 7-17
2. Burgdorfer W., Barbour A.G., Hayes S.F., et al. Lyme disease-a tick-borne spirochetosis?. Science 216 (1982) 1317-1319
3. Snydman D.R., Schenkein D.P., Berardi V.P., et al. Borrelia burgdorferi in joint fluid in chronic Lyme arthritis. Ann Intern Med 104 (1986) 798-800
4. Nocton J.J., Dressler F., Rutledge B.J., et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 330 (1994) 229-234
5. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43 (2006) 1089-1134
6. Steere A.C., and Glickstein L. Elucidation of Lyme arthritis. Nat Rev Immunol 4 (2004) 143-152
7. Guerau-de-Arellano M., and Huber B.T. Chemokines and toll-like receptors in Lyme disease pathogenesis. Trends Mol Med 11 (2005) 114-120
8. Coburn J., Fischer J.R., and Leong J.M. Solving a sticky problem: new genetic approaches to host cell adhesion by the Lyme disease spirochete. Mol Microbiol 57 (2005) 1182-1195
9. Hu L.T., Eskildsen M.A., Masgala C., et al. Host metalloproteinases in Lyme arthritis. Arthritis Rheum 44 (2001) 1401-1410
10. Behera A.K., Hildebrand E., Scagliotti J., et al. Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine Lyme arthritis. Infect Immun 73 (2005) 126-134
11. Carlson D., Hernandez J., Bloom B.J., et al. Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum 42 (1999) 2705-2709
12. Girschick H.J., Huppertz H.I., Russmann H., et al. Intracellular persistence of Borrelia burgdorferi in human synovial cells. Rheumatol Int 16 (1996) 125-132
13. Steere A.C., Dwyer E., and Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 323 (1990) 219-223
14. Kalish R.A., Leong J.M., and Steere A.C. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 61 (1993) 2774-2779
15. Gross D.M., Forsthuber T., Tary-Lehmann M., et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281 (1998) 703-706
16. Steere A.C., Gross D., Meyer A.L., et al. Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis. J Autoimmun 16 (2001) 263-268
17. Guerau-de-Arellano M., and Huber B.T. Development of autoimmunity in Lyme arthritis. Curr Opin Rheumatol 14 (2002) 388-393
18. Drouin E.E., Glickstein L.J., and Steere A.C. Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato. J Autoimmun 23 (2004) 281-292
19. Steere A.C., Klitz W., Drouin E.E., et al. Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J Exp Med 203 (2006) 961-971
20. Trollmo C., Meyer A.L., Steere A.C., et al. Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells. J Immunol 166 (2001) 5286-5291
21. Kannian P., Drouin E.E., Glickstein L., et al. Decline in the frequencies of Borrelia burgdorferi OspA161 175-specific T cells after antibiotic therapy in HLA-DRB1*0401-positive patients with antibiotic-responsive or antibiotic-refractory Lyme arthritis. J Immunol 179 (2007) 6336-6342
22. Steere A.C., Schoen R.T., and Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 107 (1987) 725-731
23. CDC. Recommendations for test performance and interpretation from the second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 44 (1995) 590-591
24. Aguero-Rosenfeld M.E., Wang G., Schwartz I., et al. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 18 (2005) 484-509
25. CDC. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep 46 (1997) 20-21
26. Lawson J.P., and Steere A.C. Lyme arthritis: radiologic findings. Radiology 154 (1985) 37-43
27. Steere A.C., Malawista S.E., Hardin J.A., et al. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med 86 (1977) 685-698
28. Liebling M.R., Nishio M.J., Rodriguez A., et al. The polymerase chain reaction for the detection of Borrelia burgdorferi in human body fluids. Arthritis Rheum 36 (1993) 665-675
29. Sigal L.H. The polymerase chain reaction assay for Borrelia burgdorferi in the diagnosis of Lyme disease. Ann Intern Med 120 (1994) 520-521
30. Bradley J.F., Johnson R.C., and Goodman J.L. The persistence of spirochetal nucleic acids in active Lyme arthritis. Ann Intern Med 120 (1994) 487-489
31. Hu L. Lyme arthritis. Infect Dis Clin North Am 19 (2005) 947-961
32. Steere A.C., and Angelis S.M. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum 54 (2006) 3079-3086
33. Dattwyler R.J., Luft B.J., Kunkel M.J., et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 337 (1997) 289-294
34. Nadelman R.B., and Wormser G.P. Reinfection in patients with Lyme disease. Clin Infect Dis 45 (2007) 1032-1038
35. Schoen R.T., Aversa J.M., Rahn D.W., et al. Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy. Arthritis Rheum 34 (1991) 1056-1060
36. Shin J.J., Glickstein L.J., and Steere A.C. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory Lyme arthritis. Arthritis Rheum 56 (2007) 1325-1335
37. Brorson O., and Brorson S.H. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine. Int Microbiol 5 (2002) 25-31
38. Fox R.I. Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin Arthritis Rheum 23 (1993) 82-91
39. Yrjanainen H., Hytonen J., Song X.Y., et al. Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice. J Infect Dis 195 (2007) 1489-1496
40. Smith R.P., Schoen R.T., Rahn D.W., et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med 136 (2002) 421-428
41. Feder Jr. H.M., Johnson B.J., O'Connell S., et al. A critical appraisal of "chronic Lyme disease". N Engl J Med 357 (2007) 1422-1430
42. Cairns V., and Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol 34 (2005) 1340-1345
43. Shapiro E.D., Dattwyler R., Nadelman R.B., et al. Response to meta-analysis of Lyme borreliosis symptoms. Int J Epidemiol 34 (2005) 1437-1439